Teligent Inc (TLGT) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Teligent Inc   (NASDAQ: TLGT)
 

Teligent Inc Growth Comparisons

Select each growth Category to receive further Information





TLGT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) -23.21 % 28.73 % 31.47 % 32.25 %
Q / Q Revenue Growth (Q2 MRQ) -9.97 % 8.61 % 7.15 % 5.39 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) -16.53 % 19.62 % 16.76 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) -6.38 % 6.64 % 6.88 % 6.95 %
Revenue 5 Year Average Growth 0.47 % 15.56 % 10.85 % 9.03 %


TLGT's Growth Comparisons in II. Quarter 2021




Teligent Inc 's sharp decrease of -23.21% in sales in the second quarter from the same quarter a year ago, those results deviated strongly from rising Revenue in Major Pharmaceutical Preparations industry with 28.73%, and underperformed the 31.47% Revenue increase in the Healthcare sector. Weak second quarter sales, in Major Pharmaceutical Preparations industry and within the Healthcare sector, were reflected in Teligent Inc results which underperformed overall market.

Top-line fell by -9.97% from the first quarter. Average annual sales growth for Teligent Inc is 0.47%, while S & P 500's average yearly sales increase is 9.03%, including only Businesses with the second quarter 2021 financial results.


Growth Rates of TLGT's Income in the second quarter 2021


TLGT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - 87.39 % 102.39 % 143.25 %
Sequential Operating Income Change (Q2 MRQ) - 0.8 % -1.16 % 2.82 %
Y / Y Operating Income Growth (Q2 TTM) - -8.92 % 22.48 % 33.04 %
Sequential Operating Income Growth (Q2 TTM) - 21.03 % 18.84 % 22.34 %
Operating Income 5 Year Avg. Change - 9.21 % 2.2 % 8.2 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - 63.34 % 106.52 % 250.54 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - -15.94 % -4.82 % 3.25 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - -0.79 % 26.04 % 57.05 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - 20.82 % 24.16 % 29.09 %
Income from Cont. Ops. 5 Year Avg. Change - 22.71 % 10.33 % 76.07 %

TLGT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - 68.48 % 119.23 % 278.45 %
Q / Q Net Income Growth (Q2 MRQ) - -13.19 % -3.05 % 9.61 %
Y / Y Net Income Change (Q2 TTM) - 0.69 % 27.61 % 61.81 %
Sequential Net Income Change (Q2 TTM) - 22.16 % 25.97 % 31.91 %
Net Income 5 Year Avg. Growth - 9.2 % 1.77 % 4.21 %

TLGT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - 35.65 % 106.52 % 250.54 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - -15.84 % -4.82 % 3.25 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - 0.05 % -0.1 % 17688.28 %
EPS from Cont. Ops. 5 Year Avg. Growth - 8.11 % 10.33 % 76.07 %



TLGT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - 39.92 % 119.23 % 76.07 %
Q / Q EPS Net Growth (Q2 MRQ) - -13.09 % -3.05 % 9.61 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 14997.19 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - - - 18042.19 %
EPS Net 5 Year Avg. Change - 9.2 % 1.77 % 4.21 %



Teligent Inc reported bottom-line of $ -0.14 in the second quarter, compare to $ -2.56 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 39.92%, while Healthcare sector increased by 119.23%, and overall market improved by 278.45%.

the bottom-line fell by -9.97% from the first quarter. Average annual income per share growth for Teligent Inc is 0.47%, while S & P 500's average yearly income per share increase is 4.21%, including only Businesses with the second quarter 2021 earnings.

TLGT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - 25.56 % -6.88 % 25.63 %
Sequential Free Cash Flow Change (Q2 MRQ) - 28.9 % 15.66 % 83.3 %
Y / Y Free Cash Flow Change (Q2 TTM) - 24.49 % 16.76 % -3.7 %
Sequential Free Cash Flow Change (Q2 TTM) - 5.88 % -1.56 % 8.06 %
Free Cash Flow 5 Year Avg. Change - 18.63 % 14.45 % 20.95 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - 64.54 % -
Sequential Net Cash Flow Change (Q2 MRQ) - - 456.79 % -
Y / Y Net Cash Flow Change (Q2 TTM) 614.7 % -61.9 % -93.2 % -83.46 %
Sequential Net Cash Flow Change (Q2 TTM) - - -0.11 % -71.83 %
Net Cash Flow 5 Year Avg. Change - 49.51 % 45.88 % 111.49 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) -87.78 % 14.25 % 19.36 % 11.3 %
Sequential Capital Expenditures Change (Q2 MRQ) 287.23 % 4.46 % 6.38 % -2.67 %
Y / Y Capital Expenditures Change (Q2 TTM) -65.38 % 17.01 % 9.48 % -2.9 %
Sequential Capital Expenditures Change (Q2 TTM) -40.83 % 0.86 % 1.39 % 2.66 %
Capital Expenditures 5 Year Avg. Change - 16.07 % 10.75 % 10.77 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.